Mark Finkelstein

1.6k total citations
37 papers, 1.1k citations indexed

About

Mark Finkelstein is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Mark Finkelstein has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Biomedical Engineering and 6 papers in Molecular Biology. Recurrent topics in Mark Finkelstein's work include Biofuel production and bioconversion (5 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Microbial Metabolic Engineering and Bioproduction (3 papers). Mark Finkelstein is often cited by papers focused on Biofuel production and bioconversion (5 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Microbial Metabolic Engineering and Bioproduction (3 papers). Mark Finkelstein collaborates with scholars based in United States, Germany and Japan. Mark Finkelstein's co-authors include Min Zhang, C K Eddy, Stephen Picataggio, Brian H. Davison, James D. McMillan, Barbara R. Evans, Michael Palese, James W. Lee, R H Rownd and Jay R. Horton and has published in prestigious journals such as Science, PEDIATRICS and Critical Care Medicine.

In The Last Decade

Mark Finkelstein

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Finkelstein United States	16	689	599	113	74	74	37	1.1k
Holger Klose Germany	23	593 0.9×	349 0.6×	185 1.6×	345 4.7×	171 2.3×	68	1.5k
Srđan Novak Croatia	14	411 0.6×	314 0.5×	60 0.5×	26 0.4×	27 0.4×	61	882
Thomas R. Hanley United States	16	325 0.5×	214 0.4×	50 0.4×	16 0.2×	20 0.3×	65	876
Wenming Zhang China	26	205 0.3×	588 1.0×	61 0.5×	215 2.9×	218 2.9×	66	1.5k
Malin Svensson Sweden	15	86 0.1×	497 0.8×	92 0.8×	65 0.9×	100 1.4×	22	1.6k
Yajuan Xie China	15	292 0.4×	152 0.3×	31 0.3×	14 0.2×	80 1.1×	35	915
Lili Li China	18	82 0.1×	517 0.9×	34 0.3×	106 1.4×	71 1.0×	33	1.2k
Haotian Wang China	16	144 0.2×	351 0.6×	40 0.4×	475 6.4×	48 0.6×	75	1.2k
Xinying Wang China	19	106 0.2×	294 0.5×	19 0.2×	84 1.1×	214 2.9×	86	1.3k
Sai Liu China	19	99 0.1×	451 0.8×	36 0.3×	124 1.7×	76 1.0×	66	1.2k

Countries citing papers authored by Mark Finkelstein

Since Specialization

Citations

This map shows the geographic impact of Mark Finkelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Finkelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Finkelstein more than expected).

Fields of papers citing papers by Mark Finkelstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Finkelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Finkelstein. The network helps show where Mark Finkelstein may publish in the future.

Co-authorship network of co-authors of Mark Finkelstein

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Finkelstein. A scholar is included among the top collaborators of Mark Finkelstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Finkelstein. Mark Finkelstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Finkelstein, Mark, et al.. (2025). Next-Generation Advances in Prostate Cancer Imaging and Artificial Intelligence Applications. Journal of Imaging. 11(11). 390–390.

Finkelstein, Mark, et al.. (2022). Regional trends of minimally invasive radical hysterectomy for cervical cancer and exploration of perioperative outcomes. Cancer Epidemiology. 77. 102095–102095. 4 indexed citations

Finkelstein, Mark, et al.. (2019). Radical Prostatectomy Sociodemographic Disparities Based on Hospital and Physician Volume. Clinical Genitourinary Cancer. 17(5). e1011–e1019. 4 indexed citations

Finkelstein, Mark, et al.. (2019). MP08-12 UTILIZATION TRENDS AND 90-DAY TREATMENT-FREE RATES FOR ESWL, URS, AND PCNL CASES IN THE INPATIENT AND OUTPATIENT SETTING BETWEEN 2004-2014. The Journal of Urology. 201(Supplement 4).

Finkelstein, Mark, et al.. (2017). Modified frailty index associated with Clavien-Dindo IV complications in robot-assisted radical prostatectomies: A retrospective study. Urologic Oncology Seminars and Original Investigations. 35(6). 425–431. 47 indexed citations

Finkelstein, Mark, et al.. (2016). Trends in Subspecialization Within Inpatient Urology From 1982 to 2012. Urology. 98. 64–69. 4 indexed citations

Finkelstein, Mark, et al.. (2016). Developing triggers for the surgical intensive care unit for palliative care integration. Journal of Critical Care. 35. 7–11. 36 indexed citations

Pak, Jamie S., et al.. (2016). Utilization trends and outcomes up to 3 months of open, laparoscopic, and robotic partial nephrectomy. Journal of Robotic Surgery. 11(2). 223–229. 14 indexed citations

Spear, Michael L., Mark Finkelstein, Kathleen H Leef, et al.. (2004). Short-Term Use of Umbilical Artery Catheters May Not Be Associated With Increased Risk for Thrombosis. PEDIATRICS. 113(4). 770–774. 18 indexed citations

10.

Davison, Brian H., James W. Lee, Mark Finkelstein, & James D. McMillan. (2003). Biotechnology for Fuels and Chemicals. Humana Press eBooks. 68 indexed citations

11.

Davison, Brian H., et al.. (2002). Biotechnology for Fuels and Chemicals : the Twenty-third Symposium : proceedings of the Twenty-third Symposium on Biotechnology for Fuels and Chemicals, held May 6-9, 2001, in Breckenridge, CO. Humana Press eBooks. 1 indexed citations

12.

Davison, Brian H., James D. McMillan, & Mark Finkelstein. (2001). Twenty-Second Symposium on Biotechnology for Fuels and Chemicals. Humana Press eBooks. 22 indexed citations

13.

Finkelstein, Mark & Brian H. Davison. (2000). Twenty-First Symposium on Biotechnology for Fuels and Chemicals. Humana Press eBooks. 56 indexed citations

14.

Davison, Brian H. & Mark Finkelstein. (1999). Twentieth Symposium on Biotechnology for Fuels and Chemicals. Humana Press eBooks. 27 indexed citations

15.

Finkelstein, Mark & Brian H. Davison. (1998). Biotechnology for Fuels and Chemicals : proceedings of the Nineteenth Symposium on Biotechnology for Fuels and Chemicals, held May 4-8, 1997, at Colorado Springs, Colorado. Humana Press eBooks. 2 indexed citations

16.

Mohagheghi, Ali, et al.. (1998). Cofermentation of glucose, xylose, and arabinose by mixed cultures of two genetically engineeredZymomonas mobilis strains. Applied Biochemistry and Biotechnology. 70-72(1). 285–299. 16 indexed citations

17.

Finkelstein, Mark, et al.. (1998). Estimating the Probabilities of Runs of Identical Events Within Biological Sequences. Molecular Biology and Evolution. 15(4). 470–472. 1 indexed citations

18.

Davison, Brian H., Charles E. Wyman, & Mark Finkelstein. (1997). Biotechnology for Fuels and Chemicals : proceedings of the Eighteenth Symposium on Biotechnology for Fuels and Chemicals, held May 5-9, 1996, at Gatlinburg, Tennessee. Humana Press eBooks. 1 indexed citations

19.

Siskin, Stewart B., et al.. (1993). THE EFFECTS OF AMMONIUM LACTATE 12% LOTION VERSUS NO THERAPY IN THE TREATMENT OF DRY SKIN OF THE HEELS. International Journal of Dermatology. 32(12). 905–907. 8 indexed citations

20.

Finkelstein, Mark, et al.. (1990). Granular cell tumor of the heel. Journal of the American Podiatric Medical Association. 80(11). 608–610. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact